Is cell salvage cost-effective in posterior arthrodesis for adolescent idiopathic scoliosis in the public health system?
| Autor: | Paulo César de Almeida, Francisco Valmir Fernandes, Fernando A M Façanha Filho, Saulo Rabelo Lima Verde, José A A Oliveira, Vládia F de Oliveira |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
030222 orthopedics
medicine.medical_specialty business.industry medicine.medical_treatment Public health Arthrodesis Significant difference Idiopathic scoliosis Scoliosis medicine.disease Confidence interval Surgery 03 medical and health sciences 0302 clinical medicine Spinal fusion medicine Orthopedics and Sports Medicine In patient Original Study business 030217 neurology & neurosurgery |
| Zdroj: | Journal of spine surgery (Hong Kong). 3(1) |
| ISSN: | 2414-469X |
| Popis: | Background: To evaluate the efficacy and cost-effectiveness of cell salvage (CS) in reducing allogeneic transfusion in patients undergoing surgery for idiopathic scoliosis. Methods: A case-control study with 42 patients with adolescent idiopathic scoliosis (AIS), submitted to posterior arthrodesis with instrumentation from 8/2008 to 12/2014 at the General Hospital of Fortaleza, Brazil. CS was used in 27 patients and not used in 15. The data was processed using the SPSS 20.0. The confidence level was 0.05. Results: There were no significant differences between the groups for the variables of age, sex, preoperative weight, postoperative blood drainage, and surgical time. There was a significant reduction in the intra-operative allogeneic transfusion in the case group compared to the control; there was no significant difference in the postoperative period. Adding the two periods together there was a significant difference with less allogeneic red blood cells (RBC) transfused in the CS group. The total cost of allogeneic RBC between the intra and postoperative groups was higher in the control group (P=0.01). Due to this difference ($350.00-$136.93) the cost was $213.07. The net savings were $213.07. Multiplying this by the 27 subjects, allogeneic RBC transfusion led to a cost reduction of $5,752.89 for the State. Conclusions: The CS was effective in reducing allogeneic transfusion during surgery and in the total period that AIS patients underwent surgery it was also cost-effective. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|